...
【24h】

Sternotomy Versus Nonsternotomy LIMA-LAD Grafting for Single-Vessel Disease

机译:立体切开术与非立体切开术LIMA-LAD移植治疗单支血管疾病

获取原文

摘要

Surgical TechniquesMIDCABEndoACABRADCABEndoACABOutcomesStatistical AnalysisDiscussionReferencesSingle-vessel disease of the left anterior descending (LAD) coronary artery may be surgically revascularized by left internal mammary artery (LIMA) grafting either through a sternotomy or a nonsternotomy approach. Nonsternotomy approaches are used in the hope of achieving a less invasive operation. It is unknown whether nonsternotomy approaches impact in-hospital or midterm outcomes.MethodsThe institutional Society of Thoracic Surgeons (STS) database at a single US academic center was reviewed for 597 consecutive patients treated surgically for single-vessel LAD disease from January 1, 2002 to June 30, 2011. In-hospital adverse events and length of stay (LOS) were compared between patients who had LIMA-LAD grafting performed through a sternotomy (sternotomy patients) versus patients who had this procedure performed through a nonsternotomy approach (nonsternotomy patients), adjusted for propensity score (likelihood of receiving sternotomy, calculated on 33 variables). Midterm survival between groups was compared using Kaplan-Meier and Cox regression analysis by referencing the National Social Security Death Index.ResultsThere were 597 consecutive patients who underwent single-vessel grafting by LIMA-LAD coronary artery grafting. Of these patients, 234 underwent sternotomy, whereas 363 patients had nonsternotomy procedures: 239 patients had endoscopic LIMA harvest and left anterolateral thoracotomy, 106 patients had robot LIMA harvest and left anterolateral thoracotomy, and 18 patients had minimally invasive direct coronary artery bypass. There were no strokes in the nonsternotomy group and 3 (1.3%) in the sternotomy group (p = 0.031). Thirty-day mortality, incidence of myocardial infarction, hospital LOS, and midterm survival were similar between groups. Operative time was significantly longer in the nonsternotomy group (1.8 hours, 95% confidence interval [CI], 1.5–2.1).ConclusionsIn this propensity-adjusted comparison, sternal-sparing incisions were associated with similar 30-day adverse events and midterm survival compared with sternotomy for single-vessel LIMA–LAD artery grafting.Abbreviations and Acronyms: AOR (adjusted odds ratio), CABG (coronary artery bypass grafting), CI (confidence intervals), EndoACAB (endoscopic atraumatic coronary artery bypass), ICU (intensive care unit), LAD (left anterior descending), LIMA (left internal mammary artery), LOS (length of stay), MACE (major adverse cardiac events), MIDCAB (minimally invasive direct coronary artery bypass), RADCAB (robotically assisted direct coronary artery bypass), STS (Society of Thoracic Surgeons), TECAB (robotically assisted totally endoscopic coronary artery bypass)CTSNet classification:23Dr Halkos discloses that he has a financial relationship with Intuitive Surgical, Inc; Dr Vassiliades with Medtronic, Inc; and Dr Thourani with Maquet.In the current era, coronary artery bypass grafting (CABG) is typically performed for patients with multivessel disease. However given that the survival advantage of CABG is mainly attributable to the left internal mammary artery (LIMA)-to-left anterior descending (LAD) artery graft [
机译:外科手术技术MIDCABEndoACABRADCABEndoACAB结果统计分析非胸骨切开术方法被期望实现侵入性较小的手术。方法尚不清楚非胸骨切开术是否会影响住院或中期结局。方法:回顾2002年1月1日至2002年1月在美国一家学术中心的胸外科医师学会(STS)数据库,对连续手术治疗的597例单血管LAD疾病患者进行回顾。 2011年6月30日。比较了通过胸骨切开术进行LIMA-LAD移植的患者(胸骨切开术患者)与通过非胸骨切开术进行此过程的患者(非胸骨切开术患者)的院内不良事件和住院时间(LOS)。 ,针对倾向得分进行了调整(接受胸骨切开术的可能性,根据33个变量计算得出)。通过参考国家社会保障死亡指数,使用Kaplan-Meier和Cox回归分析比较各组之间的中期存活率。结果有597例连续患者通过LIMA-LAD冠状动脉移植进行了单血管移植。在这些患者中,有234例接受了胸骨切开术,而有363例进行了非胸骨切开术:239例接受了内镜下LIMA采集和左前胸廓切开术,106例进行了机器人LIMA采集和左前侧胸廓切开术,18例进行了微创直接冠状动脉搭桥术。非胸骨切开术组没有中风,胸骨切开术组没有3(1.3%)(p = 0.031)。两组之间的30天死亡率,心肌梗死发生率,医院LOS和中期生存率相似。非胸骨切开术组的手术时间显着延长(1.8小时,置信区间[CI]为1.5-2.1,1.5%至2.1%)。结论在这一倾向性调整比较中,保留胸骨切口与30天相似的不良事件和中期生存率相关胸骨切开术用于单支LIMA–LAD动脉移植。缩写和首字母缩写:AOR(调整比值比),CABG(冠状动脉搭桥术),CI(置信区间),EndoACAB(内镜无创冠状动脉搭桥术),ICU(重症监护)单位),LAD(左前降支),LIMA(左乳内动脉),LOS(住院时间),MACE(严重心脏不良事件),MIDCAB(微创直接冠状动脉旁路手术),RADCAB(机器人辅助直接冠状动脉) CTSNet分类:23 Halkos博士透露,他与Intuitive Surgical有财务往来关系,STS(胸外科医师学会),TECAB(机器人辅助全内镜冠状动脉搭桥术)公司; Vassiliades博士,美敦力公司;在当前时代,多血管疾病患者通常进行冠状动脉旁路移植术(CABG)。然而,鉴于CABG的生存优势主要归因于左乳内动脉(LIMA)至左前降支(LAD)动脉移植物[

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号